Stockscreener 앱 받기
4.20
9.80%
0.375
시간 외 거래:
4.20
전일 마감가:
$3.825
열려 있는:
$3.85
하루 거래량:
475.01K
Relative Volume:
2.77
시가총액:
$75.03M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-5.122
EPS:
-0.82
순현금흐름:
$153.00K
1주 성능:
-30.69%
1개월 성능:
-37.41%
6개월 성능:
-66.90%
1년 성능:
-57.45%
1일 변동 폭
$3.82
$4.29
1주일 범위
$3.78
$6.36
52주 변동 폭
$3.78
$16.64
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| OPRX | 4.20 | 75.03M | 62.81M | -13.75M | 153.00K | -0.82 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
OptimizeRx to Participate in Upcoming Investor Conferences - The Manila Times
OptimizeRx to Present at ROTH and Canaccord Genuity Healthcare Conferences in NYC | OPRX Stock News - StockTitan
Janney Montgomery Scott LLC Buys Shares of 104,917 OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Brokerages Set OptimizeRx Co. (NASDAQ:OPRX) Price Target at $11.58 - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Earnings Call Transcript - Insider Monkey
AWM Investment Company's Strategic Acquisition of OptimizeRx Cor - GuruFocus.com
Divisadero Street Capital Management's Strategic Acquisition of OptimizeRx Shares - GuruFocus.com
OptimizeRx's (OPRX) "Buy" Rating Reiterated at Roth Mkm - MarketBeat
Optimizerx stock hits 52-week low at $4.69 amid market challenges - Investing.com Nigeria
Earnings call: OptimizeRx reports 30% revenue growth in Q3 By Investing.com - Investing.com UK
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $8.00 by Analysts at Stifel Nicolaus - MarketBeat
JMP Securities Lowers OptimizeRx (NASDAQ:OPRX) Price Target to $8.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Given New $5.00 Price Target at Barclays - MarketBeat
Earnings call: OptimizeRx reports 30% revenue growth in Q3 - Investing.com India
OPTIMIZERx earnings beat by $0.06, revenue fell short of estimates - Investing.com
OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates - Yahoo Finance
OptimizeRx Reports Third Quarter 2024 Financial Results - The Manila Times
OptimizeRx Q3 Revenue Jumps 30% to $21.3M, Updates 2024 Guidance | OPRX Stock News - StockTitan
OptimizeRx (OPRX) Scheduled to Post Earnings on Wednesday - Defense World
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Wednesday - Defense World
OptimizeRx (OPRX) Surges 19.8%: Is This an Indication of Further Gains? - MSN
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Rice Hall James & Associates LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizRx stock hits 52-week low at $5.42 amid market challenges - Investing.com India
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - The Manila Times
Optimizerx stock hits 52-week low at $6.29 amid market shifts - Investing.com
Squarepoint Ops LLC Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Renaissance Technologies LLC - Defense World
American Century Companies Inc. Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? - Yahoo Finance
Optimizerx stock hits 52-week low at $6.92 amid market shifts By Investing.com - Investing.com South Africa
Optimizerx stock hits 52-week low at $6.92 amid market shifts - Investing.com Australia
OptimizeRx's SWOT analysis: digital health firm faces growth challenges By Investing.com - Investing.com UK
OptimizeRx's SWOT analysis: digital health firm faces growth challenges - Investing.com
Rhumbline Advisers Increases Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of New York Mellon Corp - Defense World
Divisadero Street Capital Management LP Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
OptimizeRx expands pharma client engagement to $10M - Investing.com
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a - The Bakersfield Californian
OptimizeRx Launches Novel Brand Eligibility Technology - Martechcube
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - ForexTV.com
Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00 - Defense World
Vanguard Group Inc. Raises Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00 - Defense World
A Closer Look at 5 Analyst Recommendations For OptimizeRx - Benzinga
Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 - Yahoo Finance
OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK
Contrasting OptimizeRx (NASDAQ:OPRX) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) - Defense World
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
0.23%
자본화:
|
볼륨(24시간):